Adverse drug reactions in special populations–the elderly

EA Davies, MS O'mahony - British journal of clinical …, 2015 - Wiley Online Library
The International Conference on Harmonization considers older people a 'special
population', as they differ from younger adults in terms of comorbidity, polypharmacy …

Adverse drug reactions in special populations-the elderly

EA Davies, MS O'Mahony - British journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
The International Conference on Harmonization considers older people a'special
population', as they differ from younger adults in terms of comorbidity, polypharmacy …

Adverse drug reactions in special populations-the elderly.

EA Davies, MS O'Mahony - British Journal of Clinical Pharmacology, 2015 - europepmc.org
Abstract The International Conference on Harmonization considers older people a 'special
population', as they differ from younger adults in terms of comorbidity, polypharmacy …

[引用][C] Adverse drug reactions in special populations-the elderly

EA Davies, MS O'Mahony - British Journal of Clinical Pharmacology, 2015 - cir.nii.ac.jp
Adverse drug reactions in special populations - the elderly | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Adverse drug reactions in special populations–the elderly

EA Davies, MS O'Mahony - British Journal of Clinical Pharmacology, 2015 - infona.pl
The International Conference on Harmonization considers older people a 'special
population', as they differ from younger adults in terms of comorbidity, polypharmacy …

[HTML][HTML] Adverse drug reactions in special populations–the elderly

EA Davies, MS O'Mahony - British Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Abstract The International Conference on Harmonization considers older people a 'special
population', as they differ from younger adults in terms of comorbidity, polypharmacy …

Adverse drug reactions in special populations-the elderly.

EA Davies, MS O'Mahony - British Journal of Clinical Pharmacology, 2015 - europepmc.org
Abstract The International Conference on Harmonization considers older people a 'special
population', as they differ from younger adults in terms of comorbidity, polypharmacy …